相关实验视频

Updated: Jun 27, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

新辅助疗法导致肝脏内胆管癌的客观反应

Benjamin J Van Treeck¹, Maria C Olave¹, Ryan D Watkins²

¹Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN, USA.

HPB : the official journal of the International Hepato Pancreato Biliary Association

|May 5, 2024

概括

在肝内胆管癌 (iCCA) 中的新辅助疗法可能有助于手术护理,但没有显著改变生存结果. 需要进一步的研究来探索其作为iCCA有效治疗范式的潜力.

科学领域:

肝胆道恶性瘤肝胆道恶性瘤
手术瘤学手术瘤学
胃肠道瘤学胃肠道瘤学

背景情况:

肝脏内胆管癌 (iCCA) 是一种流行且具有攻击性的肝癌,治疗选择有限.
手术切除是可切除iCCA的主要治疗方法,但许多患者存在高风险特征.
新辅助全身疗法越来越多地被认为是高风险的ICCA患者,但其临床影响仍在研究中.

研究的目的:

评估新辅助疗法的临床效果在患有瘤高风险肝脏内胆管癌的患者.
为了比较iCCA患者接受新辅助疗法后进行手术的结果与仅接受手术的患者之间的结果.

主要方法:

一项回顾性队列研究审查了181名iCCA患者 (2014-2020年).
数据包括临床,组织病理,治疗和结果信息.
使用胃肠道癌的CAP标准来评估瘤回归.

主要成果:

在181名患者中,47人接受了新辅助疗法,72人没有.
新辅助治疗显示出客观反应和瘤回归.
经过关键因素调整后,在经过手术后的新辅助疗法和先进行手术之间没有观察到显著的结果差异.

结论:

在iCCA中,新辅助疗法可以促进手术干预.
无进展和整体存活率在接受新辅助治疗或不接受新辅助治疗的手术患者之间没有显著差异.
新辅助疗法在iCCA中的作用需要进一步探索,作为潜在的治疗策略.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.